Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells: An integrated molecular profiling approach
about
The role of Snail in prostate cancerThe cancer stem cell niche--there goes the neighborhood?Galiellalactone inhibits stem cell-like ALDH-positive prostate cancer cellsPathobiological implications of the expression of EGFR, pAkt, NF-κB and MIC-1 in prostate cancer stem cells and their progeniesIndependent component analysis: mining microarray data for fundamental human gene expression modulesGossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells.Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma.Novel therapies against aggressive and recurrent epithelial cancers by molecular targeting tumor- and metastasis-initiating cells and their progenies.The sesquiterpene lactone dehydroleucodine triggers senescence and apoptosis in association with accumulation of DNA damage markers.Identification of vitronectin as an extrinsic inducer of cancer stem cell differentiation and tumor formation.Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies.Animal models relevant to human prostate carcinogenesis underlining the critical implication of prostatic stem/progenitor cells.Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells.Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis.New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells.Parthenolide reduces the frequency of ABCB5-positive cells and clonogenic capacity of melanoma cells from anchorage independent melanospheres.Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancerCryptotanshinone targets tumor-initiating cells through down-regulation of stemness genes expression.Discovery of potent parthenolide-based antileukemic agents enabled by late-stage P450-mediated C-H functionalization.In human retinoblastoma Y79 cells okadaic acid-parthenolide co-treatment induces synergistic apoptotic effects, with PTEN as a key player.Mechanisms of Chromosome Congression during Mitosis.Towards novel paradigms for cancer therapy.Sesquiterpene lactones: adverse health effects and toxicity mechanisms.The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer.Anticancer activity profiling of parthenolide analogs generated via P450-mediated chemoenzymatic synthesis.Elimination of ALDH+ breast tumor initiating cells by docosahexanoic acid and/or gamma tocotrienol through SHP-1 inhibition of Stat3 signaling.SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin.Inhibition of Myb-dependent gene expression by the sesquiterpene lactone mexicanin-I.Cell context-dependent activities of parthenolide in primary and metastatic melanoma cellsPharmacological targeting of glucose-6-phosphate dehydrogenase in human erythrocytes by Bay 11-7082, parthenolide and dimethyl fumarate.Cancer complementary and alternative medicine research at the US National Cancer Institute.Targeting CDK6 and BCL2 exploits the "MYB addiction" of Ph+ acute lymphoblastic leukemia.The plant sesquiterpene lactone parthenoide inhibits Wnt/β-catenin signaling by blocking synthesis of the transcriptional regulators TCF4/LEF1.Parthenolide facilitates apoptosis and reverses drug-resistance of human gastric carcinoma cells by inhibiting the STAT3 signaling pathway.Platinum-catalyzed cycloisomerizations of a common enyne: a divergent entry to cyclopropane sesquiterpenoids. Formal synthesis of sarcandralactone A.Synergistic anti-cancer effects of epigenetic drugs on medulloblastoma cells.Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3 activation.Biological Activity of Flavonoids and Rare Sesquiterpene Lactones Isolated From LSynthesis and biological evaluation of dithiocarbamate esters of parthenolide as potential anti-acute myelogenous leukaemia agentsIsolation and Structural Characterization of Bioactive Molecules on Prostate Cancer from Mayan Traditional Medicinal Plants
P2860
Q27004557-030160E3-D654-4085-B085-4913DBFBABD8Q28244178-9D2E8618-1DB2-41DD-B715-5664AA67F23BQ28478976-019689D9-57B2-4571-BAF7-9CB85B8311B5Q31049380-7B4F77BC-44C8-4EB5-ABDD-33F47B2AA6C9Q33629605-6F113738-9DA0-426C-8BB8-D674E3175367Q33647720-6932149C-7EEA-4B40-BE90-5C0828FD6CD6Q33903701-28E9BCD8-D956-4636-9AC9-3C72C38C08DDQ34382586-92345CBA-B338-46A8-91C5-5CA445975A55Q34558399-07D9BFBD-AF00-47BD-86C4-AA95D6BD3D9FQ35016861-5B79D580-C546-45EB-A5B4-407A23577B14Q35287094-DC430DA0-AD23-4AF8-9115-F60636167367Q35746535-41A85F46-72BE-4E5E-BB7C-2A6C471E653AQ35755480-98881485-CAFD-4687-864E-5890D5DE9DEEQ36407872-797B2513-302C-4207-88CF-EE20F090A4D6Q36603335-8B532352-AA27-43F6-B00D-59C73866914AQ36608707-FEF30150-A0CE-4354-B00B-52258256D763Q36910062-D8E20FC0-38AE-4E61-A339-27C1DB22DC87Q36954190-1DEAEDD4-5329-4601-AE49-325E40DE29C8Q37522487-5FFEBC1E-B1CE-4AD8-89DF-75CFFCA5492BQ37589232-09B0172C-766D-4895-9EF6-E71FD73965E8Q37728193-2D22805E-D2E4-4328-A806-B60C256D578AQ37799251-3E7E2F06-413C-493D-A341-EDAA1D347C6FQ38123215-8155D383-2EAE-44E9-964A-6770E146327EQ38203779-8F6F2118-A122-4AA0-8355-867286BE0578Q38639453-BC25F015-19B5-42C0-BF61-29CE93388B21Q38913330-206C3AD1-42D3-4DA3-980E-2FC2EE42AFACQ39021336-8FA9327C-41AA-4B50-A31B-30ED8CA06E69Q39460430-EC2CFBDD-664D-4791-862A-719593CD8131Q39686730-57A3EB2A-427E-42A9-A7CC-9254864E3862Q42519382-B38086A6-CB77-4719-BB89-2B291D837F48Q45096899-22A64BD4-A4DA-4EAF-83CD-A746C42B50A6Q48571436-3A51D78B-8742-47E2-B896-DEEFD014D064Q49806538-9859C8BA-94E2-4C79-9F3C-D5CFAF98FFF1Q50191951-34A7990B-8520-4A47-BE19-76727B2A2F47Q50791603-D5E8B5BC-BB82-4D2C-8935-40C7FD29578BQ52097904-6375F80F-1321-423E-BD8E-4BC33B92D0CCQ54603551-D46D27E8-F184-4423-9269-D006819CAF0DQ58719065-8B6A5D50-27A7-4CFA-A68F-86A9566DCD17Q58744510-A1A2070D-A54D-42C3-AE75-265D4C1ED519Q58779596-CF10AE10-1988-40A3-A1D6-AEEDDCCF8CF5
P2860
Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells: An integrated molecular profiling approach
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effects of the sesquiterpene l ...... d molecular profiling approach
@en
Effects of the sesquiterpene l ...... molecular profiling approach.
@nl
type
label
Effects of the sesquiterpene l ...... d molecular profiling approach
@en
Effects of the sesquiterpene l ...... molecular profiling approach.
@nl
prefLabel
Effects of the sesquiterpene l ...... d molecular profiling approach
@en
Effects of the sesquiterpene l ...... molecular profiling approach.
@nl
P2093
P2860
P356
P1433
P1476
Effects of the sesquiterpene l ...... d molecular profiling approach
@en
P2093
Brian T Kawasaki
Elaine M Hurt
John A Milner
Maria Ana Duhagon
William L Farrar
Young S Kim
P2860
P304
P356
10.1002/PROS.20931
P577
2009-06-01T00:00:00Z